https://iwr-1-endoinhibitor.co....m/daratumumab-pertai
DESIGN and Setting Population-based, retrospective analysis with around 12 many years of follow-up, held in Siena, Italy. MEMBERS person patients (n=153) with TMNG, naïve to RAI. METHODS Evaluation of thyroid function, anti-thyroid antibodies and ultrasound scans before and yearly after RAI. PRINCIPAL OUTCOME MEASURES Hyperthyroidism remedy, hypothyroidism; amount reduction, nadir and regain; antibody titre modification. OUT
Like
Comment
Share
